Telemedycyna Polska (WAR:TMP) Stock Based Compensation: zł0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:TMP Telemedycyna Polska SA WAR:TMP
28 GF Score
Price zł0.65
GF Value zł0.82
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Telemedycyna Polska Stock Based Compensation?

Telemedycyna Polska WAR:TMP +1.56% 28 Stock Based Compensation is zł0.00 Mil as of Mar. 2026. GuruFocus rates WAR:TMP with a GF Score™ of 28/100 and a GF Value™ of zł0.82 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Telemedycyna Polska's Stock Based Compensation for the three months ended in Mar. 2026 was zł0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was zł0.00 Mil.

Telemedycyna Polska Stock Based Compensation Related Terms

Telemedycyna Polska Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Telemedycyna Polska's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telemedycyna Polska Stock Based Compensation Chart

Telemedycyna Polska Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Telemedycyna Polska Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:TMP
28GF Score
Telemedycyna Polska SA WAR:TMP
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Telemedycyna Polska Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

What does a Stock Based Compensation of zł0.00 Mil mean?
Telemedycyna Polska (WAR:TMP) has a Stock Based Compensation of zł0.00 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Telemedycyna Polska and its competitors.
Is Telemedycyna Polska's Stock Based Compensation too high?
Telemedycyna Polska's current Stock Based Compensation is zł0.00 Mil. Overall, Telemedycyna Polska has a GF Score™ of 28/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Telemedycyna Polska's Stock Based Compensation compare to VEEV and BTSG?
Telemedycyna Polska's Stock Based Compensation of zł0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Telemedycyna Polska and its competitors. Telemedycyna Polska's current Stock Based Compensation is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telemedycyna Polska stock overvalued right now?
Based on GuruFocus' analysis, Telemedycyna Polska (WAR:TMP) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.82, compared to a current price of zł0.65 — trading 20.7% below its estimated fair value. The current Stock Based Compensation is zł0.00 Mil. Telemedycyna Polska's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Telemedycyna Polska (WAR:TMP), the current Stock Based Compensation is zł0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telemedycyna Polska (WAR:TMP) Overvalued in 2026?

Based on GuruFocus' analysis, Telemedycyna Polska stock appears to be undervalued. The current stock price of zł0.65 is trading 20.7% below its estimated GF Value™ of zł0.82. GuruFocus considers Telemedycyna Polska to be Modestly Undervalued.

Key valuation signals for WAR:TMP:

  • Stock Based Compensation: zł0.00 Mil
  • GF Value™: zł0.82 vs. price of zł0.65 (20.7% below fair value)
  • GF Score™: 28/100 with 5 warning signs

No single metric tells the full story. See the WAR:TMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Telemedycyna Polska Business Description

Address Ulica Ligocka 103, Katowice, POL, 40-568
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
28GF Score

Get the complete analysis for WAR:TMP

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.65
Price
zł0.82
GF Value